IMU

5.56%

5.7¢ imugene limited

Yep, the word ‘concludes’ jumped off the page.Says it all.We...

First 29 Last

Share
Profile

Follow
Rainman56

1,753 Posts.

433

03/04/24

09:30

Post #: 73160953
Share

Originally posted by Spozzie: ↑

I don't know about you guys but I am excited:

The abstract, titled ‘CF33-hNIS, a novel oncolytic virus for the treatment of
cholangiocarcinoma and biliary tract malignancies,’ concludes that CF33-hNIS
monotherapy may be an effective and safe treatment option for GI malignancies,
including cholangiocarcinoma, a rare disease with an unmet medical need.

Spozzie

Expand

Originally posted by jdpc35: ↑

Spot on.

This is the key quote: "The abstract, titled ‘CF33-hNIS, a novel oncolytic virus for the treatment of cholangiocarcinoma and biliary tract malignancies,’ concludes that CF33-hNIS monotherapy may be an effective and safe treatment option for GI malignancies, including cholangiocarcinoma, a rare disease with an unmet medical need."

That they are presenting with the above as the key message suggests that the results continue to stack up and they are becoming increasingly more confident of CF33 meeting the until now unmet need.

Whilst this is a rare condition in the US with "only" about 10,000 cases each year, it is way more common in Asia (by a factor of up to 6x per head of population) including a number of wealthy countries (Japan, Singapore, Taiwan, etc) with capacity to pay. Unmet need + capacity to pay = a massive financial opportunity in the near term for IMU.

If indeed the later and expanded trial results (when released) speak to the same outcomes that got them FDA fast track, then we could see this as a product in market as soon as next year. On which case I believe that there will be major players already warming up to do a deal.

Expand

Yep, the word ‘concludes’ jumped off the page.
Says it all.
We haven’t Ann the speaker.
It just might be the coming out party for Yuman LC spoke of in reference to not wanting to steal his thunder.
We present to the broad audience next week, then ride into town as the new sherif of bile duct cancer couple weeks later.
Works for me.

IMU Price at posting: 11.0¢ Sentiment: None Disclosure: Held
36 Upvote

0 Great analysis

Reply

Top Stories

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

RCE

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

There are more pages in this discussion • 193 more messages in this thread...

First 29 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.7¢		Change 0.003(5.56%)		Mkt cap ! $417.2M

Open	High	Low	Value	Volume
5.5¢	5.8¢	5.2¢	$2.499M	45.00M

Buyers (Bids)

No.	Vol.	Price($)
2	1921794	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	1368288	7

View Market Depth

No.	Vol.	Price($)
5	286362	0.055
9	2036888	0.054
16	2736044	0.053
20	1943436	0.052
23	3206056	0.051

Price($)	Vol.	No.
0.057	378902	2
0.058	1552127	7
0.059	837099	8
0.060	2176188	16
0.061	1163926	6

Last trade - 16.10pm 28/06/2024 (20 minute delay)

IMU (ASX) Chart

Yep, the word ‘concludes’ jumped off the page.Says it all.We...

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yep, the word ‘concludes’ jumped off the page.Says it all.We...

Top Stories

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Microcap Wrap: 5 explorers with news out today

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News